| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant denosumab for early breast cancer–Evidence and controversy
|
Moretti, Laura
|
|
|
78 |
C |
p.
|
artikel
|
| 2 |
AI-based strategies in breast mass ≤ 2 cm classification with mammography and tomosynthesis
|
Shao, Zhenzhen
|
|
|
78 |
C |
p.
|
artikel
|
| 3 |
A systematic review and meta-analysis of risk factors influencing patient-reported arm symptoms post-breast cancer treatment: Accounting for radiotherapy impact
|
Liang, Yuqin
|
|
|
78 |
C |
p.
|
artikel
|
| 4 |
Atypical ductal or lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia, and future risk of developing breast cancer: Systematic review and meta-analysis
|
Baker, Jannah
|
|
|
78 |
C |
p.
|
artikel
|
| 5 |
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter?
|
Pedersini, Rebecca
|
|
|
78 |
C |
p.
|
artikel
|
| 6 |
Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project
|
Valsecchi, Anna Amela
|
|
|
78 |
C |
p.
|
artikel
|
| 7 |
Can we counterbalance restricted access to innovation through specialized breast cancer care? The REAL-NOTE study
|
Matos, Leonor Vasconcelos de
|
|
|
78 |
C |
p.
|
artikel
|
| 8 |
Chemotherapy in older patients with early breast cancer
|
Schmidt, Marcus
|
|
|
78 |
C |
p.
|
artikel
|
| 9 |
Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer
|
Dai, Shuqin
|
|
|
78 |
C |
p.
|
artikel
|
| 10 |
Could macrocytosis predict survival In advanced breast cancer patients that were treated with CDK 4–6 inhibitors?
|
Gültürk, Ilkay
|
|
|
78 |
C |
p.
|
artikel
|
| 11 |
Did Michelangelo paint a young adult woman with breast cancer in “The Flood” (Sistine Chapel, Rome)?
|
Nerlich, Andreas G.
|
|
|
78 |
C |
p.
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
78 |
C |
p.
|
artikel
|
| 13 |
Effect of different exercise types on quality of life in patients with breast cancer: A network meta-analysis of randomized controlled trials
|
Li, Liang
|
|
|
78 |
C |
p.
|
artikel
|
| 14 |
Financial toxicity in breast cancer patients receiving regional nodal irradiation: Variation by cancer subtype
|
Smith, Grace L.
|
|
|
78 |
C |
p.
|
artikel
|
| 15 |
Locoregional recurrence after neoadjuvant versus adjuvant chemotherapy based on tumor subtypes in patients with early-stage breast cancer: A multi-institutional retrospective cohort study
|
Cheun, Jong-Ho
|
|
|
78 |
C |
p.
|
artikel
|
| 16 |
Major pathologic response and long-term clinical benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after neoadjuvant chemotherapy
|
Ji, Lei
|
|
|
78 |
C |
p.
|
artikel
|
| 17 |
Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer – efficacy, tolerability and quality of life results from the phase II METRO trial
|
Larsson F, Karolina
|
|
|
78 |
C |
p.
|
artikel
|
| 18 |
Multimodal ultrasound assessment of mass and non-mass enhancements by MRI: Diagnostic accuracy in idiopathic granulomatous mastitis and breast cancer
|
Yin, Liang
|
|
|
78 |
C |
p.
|
artikel
|
| 19 |
Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022
|
De Luca, A.
|
|
|
78 |
C |
p.
|
artikel
|
| 20 |
Neoadjuvant chemotherapy for radiation associated angiosarcoma (RAAS) of the breast: A retrospective single center study
|
van der Burg, Stijn J.C.
|
|
|
78 |
C |
p.
|
artikel
|
| 21 |
Nodal involvement in patients with small, clinically node-negative HER2-positive breast cancer after staging with FDG-PET/CT and neoadjuvant systemic therapy
|
van Olmen, Josefien P.
|
|
|
78 |
C |
p.
|
artikel
|
| 22 |
Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study
|
Cortés, Alfonso
|
|
|
78 |
C |
p.
|
artikel
|
| 23 |
Preoperative reference values for breast cancer patients using the BREAST-Q
|
Kuhlefelt, Charlotta
|
|
|
78 |
C |
p.
|
artikel
|
| 24 |
Radiotherapy and increased risk of second primary cancers in breast cancer survivors: An epidemiological and large cohort study
|
Hou, Niuniu
|
|
|
78 |
C |
p.
|
artikel
|
| 25 |
Real-world prevalence, treatment and survival of “high risk” early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry
|
Ladoire, Sylvain
|
|
|
78 |
C |
p.
|
artikel
|
| 26 |
Resource implications of evolving breast cancer radiotherapy treatment protocols
|
Coyle, D.J.
|
|
|
78 |
C |
p.
|
artikel
|
| 27 |
Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines
|
Groheux, David
|
|
|
78 |
C |
p.
|
artikel
|
| 28 |
Stereotactic body radiotherapy using CyberKnife versus interstitial brachytherapy in accelerated partial breast irradiation on left-sided breast: A comparison of dosimetric characteristics and preliminary clinical results
|
Wei, Ting-Na
|
|
|
78 |
C |
p.
|
artikel
|
| 29 |
The efficacy and safety of CDK4/6 inhibitors combined with endocrine therapy versus endocrine therapy alone in the adjuvant treatment of patients with high-risk invasive HR+/HER2-early breast cancer: A comprehensive updated meta-analysis of randomized clinical trials
|
Keskinkilic, Merve
|
|
|
78 |
C |
p.
|
artikel
|
| 30 |
The impact of advanced oncoplastic surgery on breast-conserving surgery rates: A retrospective cohort study of 3,875 breast cancer procedures at a tertiary referral centre
|
Reid, Angus
|
|
|
78 |
C |
p.
|
artikel
|
| 31 |
The impact of fractionation on secondary malignancies in postoperative breast cancer irradiation
|
Kiesl, Sophia
|
|
|
78 |
C |
p.
|
artikel
|
| 32 |
The incidence of male breast cancer in Klinefelter Syndrome and its proposed mechanisms
|
Cook, Benjamin
|
|
|
78 |
C |
p.
|
artikel
|
| 33 |
The “lows”: Update on ER-low and HER2-low breast cancer
|
Fusco, Nicola
|
|
|
78 |
C |
p.
|
artikel
|
| 34 |
Unveiling the future of breast cancer therapy: Cutting-edge antibody-drug conjugate strategies and clinical outcomes
|
Sun, Lu
|
|
|
78 |
C |
p.
|
artikel
|
Tijdschrift beschrijving